Menu
I'm looking for

MÖLNLYCKE NEWS

Mölnlycke latest news

Read news and updates about our company.

Mölnlycke News

New cost benefit analysis reports NHS chronic wound care costs can be reduced by use of haemoglobin spray

New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...

Mölnlycke News

Mölnlycke appoints new Chief Financial Officer

With a strong track record of financial leadership in publicly listed Swedish companies Susanne Larsson will join the company as Group Chief Financial...

Mölnlycke News

More than 9 in 10 surgeons encounter a needlestick injury

Global s urvey of  510  surgeons  is  first of its kind ;   81%   believe  high quality gloves impact patient outcomes ;     92%  agree d  that high...

Mölnlycke News

Successful EMTN programme establishment and 10-year Eurobond issue for Mölnlycke

Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly establish...

Mölnlycke News

Thousands of diabetic foot ulcer patients could benefit from topical oxygen therapy with updated treatment pathway

Mölnlycke News

Mölnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia

The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region

Mölnlycke News

Mölnlycke acquires patent for smart solutions to detect infection in wounds

The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....

Mölnlycke News

Mölnlycke acquires German wound care company SastoMed GmbH

The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...

Mölnlycke News

Creating opportunities at AZ BioVenture Hub

Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
Contact us
Cookies

We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies. You can opt out by clicking on the following link. 

Select market

Select market

We design and supply medical solutions to enhance performance in healthcare. We have representatives worldwide – you're welcome to talk to one of our sales teams or agents, or book a visit. Contact us.